Phase I trial: PXL 272092

Phase 1

• Conditions: Healthy volunteers; Not Applicable

• Registration Number: ISRCTN45338135
• Lead Sponsor: Hansa Biopharma (Sweden)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-20
• Last Update Posted: 30 May 2022
• Study Completion: 2022-09-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: Male
• Target Recruitment: 8

Inclusion Criteria

Healthy human volunteer

Exclusion Criteria

The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Study & Design

• Study Type: Interventional
• Study Design: Not specified